Scientific Program

Speaker for ICC 2021 - Michael Thompson
Keynote Presentation
Point-of-care Tool for Early Diagnosis of Ovarian Cancer
Michael Thompson, University of Toronto, Canada

High grade serous ovarian cancer (HGSOC) histologic subtypes make up the majority of epithelial ovarian cancer and 85% of cases are diagnosed at advanced stages, in which the 5-year relative survival could be as low as 20%. Unfortunately, only 20% of patients are diagnosed at sta [....]

 Leading Keynote Speaker for Cancer Conferences 2021 - Kazuko Tatsumura-Hillyer
Keynote Presentation
Effects of far-infrared & terahertz onnetsu therapy on various cancers, rheumatoid arthritis and other diseases
Kazuko Tatsumura-Hillyer, Gaia Holistic Health, USA

Introduction: Onnetsu means comfortable heat. Onnetsu Therapy invented by Dr. Kazuko Tatsumura emits from a special patented ceramic; 1) Heat 2) Precise 8-10µ of vibration of Far Infrared SunRay and 3) Vibration of Terahertz. Dr. Tatsumura is the first in the world to [....]

Keynote speaker for Cancer Conference - Jianhua Luo
Keynote Presentation
Clinical and biological roles of fusion genes in human cancers
Jianhua Luo, University of Pittsburgh, USA

Chromosome mutations and rearrangements are some of the hallmarks of human malignancies. Chromosomal rearrangement is frequent in human cancers. One of the consequences of chromosomal rearrangement is gene fusions in the cancer genome. We have identified a panel of fusion genes i [....]

Potential Keynote Speaker for Cancer Conference 2021 - Oleg Gerasimenko
Keynote Presentation
Side effect of asparaginase-based drugs for childhood all can be alleviated by galactose
Oleg Gerasimenko, Cardiff University, UK

Asparaginase-based drugs are very successful against childhood acute lymphoblastic leukaemia (ALL), however, they can induce Acute pancreatitis (AP) as a side effect and force clinicians to discontinue the treatments. AP is a frequent human disease with a substantial mortality wi [....]

Keynote Speaker for Cancer Conference 2021 - Mohammad O. Hoque
Keynote Presentation
Targeting cancer stem cells in solid tumors
Mohammad O. Hoque, Johns Hopkins University School of Medicine, USA

Cancer stem cells (CSCs) are subpopulations of tumor cells with the ability to self-renew, differentiate, and initiate and maintain tumor growth, and they are considered to be the main drivers of intra- and inter-tumoral heterogeneity. While systemic therapy (chemo and immunother [....]

Potential Speaker for Radiology Conferences 2021 - Margareta M. Muller
Keynote Presentation
Novel complex 3D in vitro models for cancer research and drug discovery
Margareta M. Muller, Hochschule Furtwangen University, Germany

To be updated soon..

Potential Speaker for Cancer Conference 2021 - Yves-Marie Robin
Oral Presentation
Real-time molecular diagnosis of soft tissue tumors using water-assisted laser desorption/ionization mass spectrometry technology
Yves-Marie Robin, Oscar Lambret Cancer Center, France

A substantial number of lesions in soft tissue pathology requires diagnostic precision for adequate patient care management and follow-up. Also, margin status of surgical specimens must be unequivocally defined, preferably intra-operatively, because of the tight relation which ex [....]

Leading Speaker for International Cancer Conference 2021 - Luigi Marongiu
Oral Presentation
Increased viral richness in colorectal cancer tissues
Luigi Marongiu, University of Heidelberg, Germany

Colorectal cancer (CRC) is a major burden for the Public Health worldwide. It has been proposed that CRC has an infectious aetiology but no statistical association has been observed between disease and microbial species. On the other hand, modification of the relative prevalence [....]

Speaker for ICC 2021 - Paola Marcato
Oral Presentation
Genome-wide comparative analysis of long non-coding RNAs versus protein-coding transcripts reveals distinct expression profiles and patient survival correlations across cancer types
Paola Marcato, Dalhousie University, Canada

Long non-coding RNAs (lncRNAs) are emerging targets for the diagnosis and therapeutic treatment of cancer. LncRNAs are non-protein-coding transcripts that regulate gene expression by modulating chromatin structure or by interacting with other RNA species. Additionally, they exhib [....]

Speaker for ICC 2021 - Wei Qiu
Oral Presentation
EPHA2, a promising therapeutic target for hepatocellular carcinoma
Wei Qiu, Loyola University Chicago, USA

Hepatocellular Carcinoma (HCC), a primary type of liver cancer, remains one of the deadliest malignancies worldwide. Despite decades of targeted therapy advancements, the currently approved medications for advanced HCC provide patients with limited clinical benefits. One major ob [....]

Speaker for ICC 2021 - Ozlem Dilek
Oral Presentation
Small molecule-based probes for monitoring carbonylation in live cells
Ozlem Dilek, University of the District of Columbia, USA

Small-molecule based probes have been used to tag biomolecules site-selectively on molecular basis to enhance diagnostic approaches in cancer. We designed a small molecule-based probe which incorporated with the carbonyl moiety of biomolecules through a click reaction to form a f [....]

Speaker for ICC 2021 - Kalliopi Megari
Oral Presentation
Neuropsychology of breast cancer patients
Kalliopi Megari, Aristotle University of Thessaloniki, Greece

Post chemotherapy cognitive impairment (PCCI), is referred to a decrease in neuropsychological performance of neurocognitive measures after chemotherapy for the treatment of cancer. Chemotherapeutic drugs are often affecting both normal and cancer cells and the cause of cognitive [....]

Potential Speaker for Cancer Conference 2021 - Alain Chapel
Oral Presentation
Clinical trial evaluating the efficacy of systemic mesenchymal stromal cell injections for the treatment of severe and chronic radiotherapy-induced abdomino-pelvic complications refractory to standard therapy
Alain Chapel, Institute of Radiological Protection and Nuclear Safety, France

The late adverse effects of pelvic radiotherapy concern 5 to 10% of patients, which could be life threatening. However, a clear medical consensus concerning the clinical management of such healthy tissue sequelae does not exist. Our group has demonstrated in preclinical animal mo [....]

Speaker for ICC 2021 - Ana Luiza de Castro Conde Toscano
Oral Presentation
AIDS related Kaposi sarcoma in Brazil
Ana Luiza de Castro Conde Toscano, Emilio Ribas Infectious Diseases Institute, Brazil

Kaposi's sarcoma (KS) is a mesenchymal tumor, caused by herpes virus type 8 (HHV-8), and a characteristic neoplasm of acquired immunodeficiency syndrome (AIDS). After the emergence of AIDS in 1980, a more aggressive form of the disease, more common among homosexual or bisexua [....]

Speaker for ICC 2021 - Eleni Petsalaki
Oral Presentation
A novel mechanism that promotes mitotic spindle formation in cancer cells
Eleni Petsalaki, University of Crete, Greece

During cell division, the mitotic spindle consists mainly of microtubules (MTs) and is essential for accurate distribution of the genetic material to the two daughter cells. Errors in spindle formation can lead to incorrect separation of chromosomes that is associated with tumori [....]

Speaker for ICC 2021 - George Zachos
Oral Presentation
Delaying the final cut: An ATM-Chk2-INCENP pathway prevents chromatin bridge breakage in cytokinesis
George Zachos, University of Crete, Greece

Chromatin bridges are strands of missegregated chromatin connecting the anaphase poles or daughter nuclei and have been linked to tumourigenesis. In response to chromatin bridges in cytokinesis, cells delay abscission, the severing of the narrow cytoplasmic canal that connects th [....]

Potential Speaker for Cancer Conference 2021 - Jehad Zweiri
Oral Presentation
The generation of anti-tumour bystander killing by genetically engineered ovarian tumour cells and the influence of y-irradiation: Implications for clinical use as cancer vaccines.
Jehad Zweiri, University of Liverpool, UK

Cellular based therapeutic approaches for cancer rely on careful consideration of finding the optimal cell to execute the cellular goal of cancer treatment. Cell lines and primary cell cultures have been used in some studies to compare the in vitro and in vivo efficacy of autolog [....]

Speaker for ICC 2021 - Izabela Mlynarczuk-Bialy
Oral Presentation
Entosis in cancer: Death or survival?
Izabela Mlynarczuk-Bialy, Medical University of Warsaw, Poland

The process of entosis is not widely known phenomenon, that can impact diagnosis and prognosis of cancer. The phenomenon is characterized by the active invasion of one cell into another and the formation of “cell in cell structures” (CIC), with the participation of Rh [....]

Eminent speaker for Oncology Conferences 2021 - Rose Anne Padua
Oral Presentation
DNA based immunotherapy for cancer: Cell wars
Rose Anne Padua, Institut de la Recherche Saint-Louis, France

To be updated soon..

Potential Speaker for Cancer Conference 2021 - Pominchuk Denis
Oral Presentation
Postoperative risk decline of complications at implementation of hypodermic mastectomy with simultaneous endoprosthetics of mammary glands for patients with the mammary gland cancer
Pominchuk Denis, "Medical Center" Verum, Ukraine

Introduction: mammary gland cancer has leading positions in the structure of woman oncologic morbidity with the most world countries. Surgical interference is the obligatory stage for patients with the early cancer of mammary gland and mastectomy is required frequently. Mode [....]

Speaker for cancer conference 2021 - Rana Ahmed Youness
Oral Presentation
Natural compounds: A gate towards better treatment of breast cancer
Rana Ahmed Youness, German University in Cairo, Egypt

To be updated soon..

Eminent speaker for Oncology Conferences 2021 - Gery Rifano Hardanto
Oral Presentation
The effect of artemisia vulgaris extract on breast cancer granzyme expression and tumor mass diameter
Gery Rifano Hardanto, Kariadi General Hospital, Indonesia

Introduction: Beside the combination of surgery, chemotherapy, and radiation as the mainstay treatment for breast cancer, the role of immunotherapy is also well recognized. The immunomodulatory effect of Artemisia vulgaris (mugwort) has recently been investigated biochemically. H [....]

Speaker for cancer conference 2021 - Hamid Yahya Hussain
Oral Presentation
Linking cancer mortality to clinical staging, grading and therapeutic modalities, over one decade, in oncology facilities, at tertiary care settings ,2019
Hamid Yahya Hussain, Dubai Health Authority, UAE

Background: Improving cancer survival is a key challenge identified in ‘improving outcomes: a strategy for cancer, and stage at diagnosis is highly predictive of cancer mortality, and a possible explanation for the difference in cancer survival. Objectives: To study&nbs [....]

Speaker for Oncology Conference 2021 - Khairy Mohamed Abdalla Zoheir
Oral Presentation
Stage 4 liver cancer healing through reiki and mexican healing therapy
Vivek Kamath, Heal the World, India

A natural energy healing technique called Reiki (Japanese Healing Method) and Mexican healing (ancient Egyptian healing method) used to heal stage 4 liver cancer patient The efforts put in my healer was just 36 hours to heal the patient and destroy the cancer cells. Total dura [....]

Speaker for Radiology Conferences 2021 - Stephen Kiptoo
Oral Presentation
Automated detection of cervical pre-cancerous using regional-based convolutional neural network
Stephen Kiptoo, Moi University, Kenya

The Classification of cervical digital images will be acquired during screening and colposopy using visual inspection with acetic acid (VIA) is an important step in automated image-based cervical cancer detection. Many of cervical images classification algorithms have been develo [....]

Speaker for cancer conference 2021 - Kenyangi Sofia Safina
Oral Presentation
Show me where cancer care is. Improving access to cancer services through trained patient navigators
Kenyangi Sofia Safina, African Cancer Control Alliance, Uganda

Introduction: A cancer diagnosis often produces an overwhelming emotional response, including feelings of shock, denial, fear, anxiety, anger, grief, and depression. Because a multitude of medical tests and consultations typically are needed to determine a definitive diagnosis an [....]

Speaker at upcoming Nursing Cancer  2021- Sathish Kottaisamy
Oral Presentation
Comparative evaluation of characteristics of neuropathic pain and its effect on quality of life in cancer patients in oncology ward and palliative care unit
Sathish Kottaisamy, Vardhman Mahavir Medical College,India

Technological advancements and recent discoveries in cancer therapy have decreased cancer-related mortality. But the principal objective of improving quality of life through advanced cancer treatments is compromised by poor management of pain (especially Neuropathic Pain (NP)) [....]

Leading Speaker of International Cancer Conference 2021- Romi Gupta
Oral Presentation
KLF7 promotes pancreatic cancer growth and metastasis by up - Regulating ISG expression and maintaining Golgi complex integrity
Romi Gupta, UAB, USA

Pancreatic ductal adenocarcinoma (PDAC) is the fourth- leading cause of cancer-related deaths in the United States and is expected to become the second-leading cause by 2020. The five-year disease-free survival rate for patients with PDAC is extremely low and has remained <10% [....]

Speaker for ICC 2021 - Anna Lian
Oral Presentation
Identification of Key Pathological Features Associated with Melanoma Survival by Artificial Intelligence NLP
Anna Lian, Brigham and Women’s Hospital/Harvard Medical School, USA

Immunotherapy has reshaped the landscape of cancer treatment, showing promising treatment responses in melanoma. Currently, there are no pathological features which consistently predict treatment responses in melanoma; existing studies have involved small cohorts and shown confli [....]

Leading Speaker for Oncology Conferences - Julia Gerasimenko
Keynote Presentation
Cell interactions in exocrine pancreas: Link to pancreatic cancer
Julia Gerasimenko, Cardiff University, UK

Acute pancreatitis (AP) is a dangerous and in up to 5% of cases deadly disease with no specific cure. AP often results in development of chronic pancreatitis (CP) and increased occurrence of pancreatic cancer (PC). The most common form of PC is pancreatic ductal adenocarcinoma an [....]

Leading Keynote Speaker for Cancer Conferences 2021 - Boguslaw Maciejewski
Keynote Presentation
Are clinical trials a road to heaven? To personalized radiotherapy
Boguslaw Maciejewski, Cancer Center-MSC Memorial Institute, Poland

Importance of randomized clinical trials aa a source for “Evidence Based Oncology” is discussed and compared with contribution of empirical clinical studies. In the early 80-ties, cure rates of conventional radiotherapy (RT) were unsatisfied, and during over 25 years [....]

Eminent speaker for Oncology Conferences 2021 - Faten Tout
Oral Presentation
The efficacy of novel anti-cancer agents dpc and dp44mt in the treatment of estrogen receptor positive breast cancer
Faten Tout, University of Sydney, Australia

Problem: The estrogen receptor α (ERα) is a major driver of breast cancer (BC), being expressed in 75% of diagnosed cases. As a result, ERα is the major therapeutic target for ERα-positive BC, with agents such as tamoxifen used to block ERα activity [....]

Speaker for cancer conference 2021 - Dragan Korolija-Marinic
Oral Presentation
University hospital "Sestre Milosrdnice" cancer center activity in the period 2014-2018
Dragan Korolija-Marinic, Clinical Hospital Center, Sisters of Mercy, Croatia

To be updated soon..

Speaker for cancer conference 2021 - Yevheniia Radzishevska
Poster Presentation
Oncologic patients have mutual relations of nosological form of the first tumour and second cancers
Yevheniia Radzishevska, Kharkiv National Medical University, Ukraine

The aim of presentstion will to demonsrate the relationship between nosological forms of the primary and second neoplasms in patients who have undergone special treatment for cancer, and who have developed second neoplasms three and  more years after the end of treatment. It [....]

Speaker for ICC 2021 - Mauriane Maja
Oral Presentation
Role of Membrane Cholesterol in Breast Cancer Cell Invasion
Mauriane Maja, de Duve Institute, Belgium

Breast cancer mortality is almost exclusively due to metastatic disease. Better molecular characterization of the primary tumor is therefore crucial for a good prediction of the clinical outcome. Breast cancer cells are characterized by aberrant lipid accumulation and metabolism. [....]

Speaker for ICC 2021 - Sergio Alexandre Alcantara dos Santos
Oral Presentation
Can prostate cancer originate in utero? Prostate carcinogenesis induced by maternal low protein diet in older offspring
Sergio Alexandre Alcantara dos Santos, São Paulo State University, Brazil

Although the carcinogenesis is frequently linked to genetic background, exposure to environmental risk factors has gained attention as the etiologic agent for several types of cancer. The intrauterine microenvironment has been described as preponderant factor for offspring health [....]

Speaker for cancer conference 2021 - Ayodeji Oteyola
Oral Presentation
Induction of abnormal sperm morphology and alterations in blood parameters and histopathology of liver, kidney and testis in mice by awba dam water
Ayodeji Oteyola, Universidade Federal de Minas Gerais, Brazil

Awba Dam is an important source of domestic water supply in the University of Ibadan, Nigeria where anthropogenic activities such as discharge of waste from hostels and households, as well as chemicals from laboratories are channeled. There is dearth of information on the genotox [....]

Organizing Committee Member 2021 - Sorush Niknamian
Keynote Presentation
Introducing the sorush cancer treatment protocol (sctp)
Sorush Niknamian, Liberty University, USA

This research introduces Sorush Cancer Treatment Ptotocol (SCTP) based on successful cancer treatment methodology which has done by Dr. Somayeh Zaminpira and Dr. Sorush Niknamian in 54 cancer patients in Violet Cancer Institute (VCI), Combining Specific Ketogenic Diet (SKD)- whic [....]

Eminent speaker for Oncology Conferences 2021 - Jyoti Mehta
Oral Presentation
Effect of photobiomodulation with low energy lasers in treatment of chemo-radiation induced oral mucositis
Jyoti Mehta, Ramaiah medical college, India

Introduction: Oral mucositis (OM) is a common side effect of chemotherapy or radiotherapy used for treating head and neck cancer. Symptoms usually start 5 to 10 days after chemotherapy or 14 days after radiotherapy and include dryness, halitosis, pain, inflammation and oral mucos [....]

Potential Speaker for Cancer Conference 2021 - Md. Mahbub Alam
Oral Presentation
Stereotactic body radiotherapy for localized peripheral lung tumor with deep inspiration breath hold technique
Md. Mahbub Alam, North East Cancer Hospital, Bangladesh

Introduction: The lungs are the major organ of our respiratory system. They help us to obtain Oxygen and get rid of Carbon dioxide from our body. It has been the most common cancer in the world since 1985 and the leading cause of cancer death. Worldwide it is by far the most co [....]

Speaker for Radiology Conferences 2021 - Rahul Hajare
Oral Presentation
How less drop out affects sex life study implementation totally less sun light pharmacy institutions in formerly reputed pune university
Rahul Hajare, India Council of Medical Research Ministry of Health Research, India

For a young woman, fewer drops out diagnosis can disrupt her body image, the intimacy with the partner and the ability to engage in sex. A fewer drops out diagnosis affects a person's sexual functioning, according to a research. The study, led by the University of Pune, found [....]

Speaker for cancer conference 2021 - Kenyangi Sofia Safina
Oral Presentation
Bridging cancer care gaps, providing homes away from home. Relevancy of cancer patients hostels in uganda
Kenyangi Sofia Safina, African Cancer Control Alliance, Uganda

Introduction: Difficulties in accessing appropriate accommodation and transport is a well-documented as a major stress factor for cancer patients seeking care at Uganda Cancer Institute (Young, 2010). A recent assessment of the needs of cancer patients at Mbarara University Cance [....]

Speaker for ICC 2021 - Mehrasa Nikandish
Oral Presentation
Types of cancer
Mehrasa Nikandish, University of Georgia, Georgia

As it is obvious, nowadays cancer is one of the most common disorders all around the world and nobody can ignore the importance of getting educated about them, types, how they spread around the body and how they can be treated and also some procedures after treatment because ever [....]

Speaker for ICC 2021 - Dellasie Aning
Oral Presentation
The Rise of Skin Cancer Prevalence in Africa and the Diaspora
Dellasie Aning, World Health Organization (UN)/ Panalove LLC/FDA of Ghana, Ghana

My objective is to bring awareness to the skin cancer trends rising within the Diaspora. My theory is in order to reduce the mortality rate, broader effort towards public awareness and education is key. Skin lightening is a wildly popular (multi billion-dollar) global industry. T [....]

Speaker for cancer conference 2021 - Mercy Masese Osoro
Oral Presentation
Patient navigation
Mercy Masese Osoro, Moi Teaching and Referral Hospital, Kenya

Who is a patient Navigator in Oncology? Patient Navigators are mostly cancer survivors assist cancer patients in overcoming barriers to receiving quality cancer care. Patient Navigators can address barriers to care (eg, psychosocial distress, transportation) and can reduce [....]

Potential Speaker for Cancer Conference 2021 - Tarek Mohamed Kamal Motawi
Poster Presentation
Significance of serum survivin and -31G/C gene polymorphism in the early diagnosis of egyptian breast cancer patients
Tarek Mohamed Kamal Motawi, Cairo University, Egypt

Background: Breast cancer is one of the most relevant malignancies among women. Molecular abnormalities in promotor region of survivin gene may account for overexpression of survivin and increased breast cancer risk. This study aimed to explore the potential association between s [....]

Speaker for cancer conference 2021 - Forooz Keshani
Oral Presentation
Serum changes of some elements in patients with oral squamous cell carcinoma: A systematic review and meta-analysis
Forooz Keshani, University of Medical Sciences, Iran

Introduction: Oral squamous cell carcinoma (OSCC) is the sixth common cancer in the world and 90% of all malignancies in the mouth. The aim of this study was investigation of changes in some metabolic elements of patient, s serum. Materials and Methods: In this study, th [....]

Speaker for Cancer Conferences 2021 - Cindy Yeoh
Poster Presentation
Anesthetic management of a patient with cancer and hyperhomocysteinemia
Cindy Yeoh, Memorial Sloan Kettering Cancer Center, USA

Case: A 57 year old female  with  a  history  of  uterine  and  breast  cancer  s/p  chemoradiation  presented  for  cervical  LEEP/cone  biopsy/D&C.  Her  medical  history  was &nb [....]

Speaker for Radiology Conferences 2021 - Achwak Fatna Bendouida
Poster Presentation
The influence of the hormonal secretion rate on the hematological and biochemical aspects of thyroid structural diseases
Achwak Fatna Bendouida, Djillali Liabes University, Algeria

Background and objective: Structural diseases of the thyroid gland are very common, predominantly female swelling. These endocrinopathy can be a benign lesion in 90% of cases and in 10% of cases be a cancer. The aim of this study was to evaluate the epidemiological profile of str [....]